{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T10:41:08Z","timestamp":1658140868757},"reference-count":0,"publisher":"Computers, Materials and Continua (Tech Science Press)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2001,8,1]]},"DOI":"10.3727\/096504001108747765","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T05:56:53Z","timestamp":1514008613000},"page":"315-323","source":"Crossref","is-referenced-by-count":2,"title":["Selective Susceptibility of Transformed T Lymphocytes to Induction of Apoptosis by PSC 833, an Inhibitor of P-Glycoprotein"],"prefix":"10.32604","volume":"12","author":[{"given":"J.","family":"Azare","sequence":"first","affiliation":[{"name":"*Nelson Institute of Environmental Medicine, New York University Medical Center, Tuxedo, NY 10987"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Pankova-Kholmyansky","sequence":"additional","affiliation":[{"name":"\u2020Department of Human Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 69978, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Salnikow","sequence":"additional","affiliation":[{"name":"*Nelson Institute of Environmental Medicine, New York University Medical Center, Tuxedo, NY 10987"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cohen","sequence":"additional","affiliation":[{"name":"\u2021Novartis Institute for Biomedical Research, Summit, NJ 07901"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Flescher","sequence":"additional","affiliation":[{"name":"\u2020Department of Human Microbiology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 69978, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/cog\/or\/2001\/00000012\/00000008\/or237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T10:05:32Z","timestamp":1658138732000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/10.3727\/096504001108747765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,1]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8,1]]}},"alternative-id":["0965-0407(20010801)12:8L.315;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504001108747765","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8,1]]}}}